Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArgentex Group. Regulatory News (AGFX)

  • This share is currently suspended. It was suspended at a price of 2.45
  • There is currently no data for AGFX

Trading Update

3 Oct 2022 07:00

RNS Number : 4482B
Argentex Group PLC
03 October 2022
 

3 October 2022

 

Argentex Group PLC

 

Trading Update

 

Argentex Group PLC ("Argentex" or the "Group"), the international provider of foreign exchange services to institutions, corporates and high net worth private individuals, today issues a trading update for the six-month period ended 30 September 2022.

Argentex expects to report six month revenues of £27.4m, a 75% increase compared to the same period last year (H1 2022: £15.7m)* with costs remaining in line with management expectations. There has been continued strong client demand with the number of corporate clients trading growing to 1,393 (H1 2022: 1,241)*.

This growth has been driven by the Group's core UK proposition and a disciplined approach to costs, in line with guidance. The performance has also been supported by more favourable market dynamics, with the recent historic lows in sterling presenting exceptional short-term trading conditions.

Momentum also continues to build behind the Company's long-term growth pillars as it creates a more technology enabled platform, adds and retains key talent and gradually builds out its international presence.

As a result, the Board is confident that the Group will exceed current market expectations for the period ended 31 December 2022.

Harry Adams, CEO of Argentex, commented: "The strong performance during the period is defined by a 75% uptick in Group revenues, demonstrating our strategy is delivering results as we unlock the long-term growth potential of Argentex."

 

"The Board is confident in the Group's ability to exceed current market expectations and to continue generating positive outcomes for clients, employees and shareholders. While current market dynamics, specifically the historic lows in sterling, present exceptional short-term trading conditions, our long-term growth strategy and outlook remain unchanged."

 

Argentex expects to report its interim results for the six months ended 30 September 2022 on Tuesday 8 November 2022.

 

*the Group has changed to a 31 December year end and for this year will report unaudited 6 months to 30 September 2022 and audited 9 months to 31 December 2022. H1 2022 refers to the period from 1 April 2021 to 30 September 2021, the first half of the last financial year ended 31 March 2022. Revenues generated in the nine months to 30 September 2022 are £36.9m, an increase of 58% compared to the same period in the prior year (9 months to September 2021 £23.4m).

 

For further information, please contact:

 

Argentex Group PLC

Harry Adams - Chief Executive Officer

Jo Stent - Chief Financial Officer

investorrelations@argentex.com

 

FTI Consulting (Financial PR)

Ed Berry / Ambrose Fullalove / Jenny Boyd

argentex@fticonsulting.com

 

Singer Capital Markets (Nominated Adviser and Broker)

Tom Salvesen / James Maxwell / Justin McKeegan

020 7496 3000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBKDBPBBDDCKK
Date   Source Headline
23rd Apr 202510:30 amRNSStatement regarding Argentex Group plc
23rd Apr 20259:48 amRNSForm 8.3 - Argentex Group plc
23rd Apr 20257:00 amRNSHolding(s) in Company
23rd Apr 20257:00 amRNSResponse to Media Speculation & Financial Position
22nd Apr 20257:40 amRNSSuspension - Argentex Group Plc
22nd Apr 20257:15 amRNSFinancial Position & Suspension of trading
15th Apr 202510:30 amRNSPublication of Annual Report and Notice of AGM
11th Apr 20254:35 pmRNSDirector/PDMR Shareholding
7th Apr 202510:21 amRNSDirector/PDMR Shareholding
4th Apr 20259:31 amRNS-RNotice of Investor Presentation
3rd Apr 20253:51 pmRNSDirector/PDMR Shareholding
2nd Apr 20254:33 pmRNSResults of GM, Grant of Awards, PDMR Notifications
2nd Apr 202512:55 pmRNSAppointment of Non-Executive Director
2nd Apr 20257:00 amRNSFinal Results
19th Mar 20257:00 amRNSNotice of Full Year Results
17th Mar 20253:00 pmRNSShareholder Circular & Notice of General Meeting
21st Jan 20257:00 amRNSTrading Update
4th Dec 202412:00 pmRNSDirector/PDMR Shareholding
9th Oct 20244:00 pmRNSCancellation of Long-Term Incentive Plan
3rd Oct 20243:00 pmRNSDirector / PDMR Dealing
1st Oct 202411:00 amRNSDirector / PDMR Dealing
18th Sep 20247:01 amRNSAppointment of Non-Executive Director
18th Sep 20247:00 amRNSInterim results for the six months to 30 June 2024
14th Aug 20247:00 amRNSNotice of Interim Results & Investor Presentation
9th Jul 20247:00 amRNSHalf year trading update
19th Jun 20245:34 pmRNSResult of AGM
6th Jun 20247:00 amRNSInvestor Presentation of FY 2023 Results
4th Jun 20247:00 amRNSAGFX secures Australian Financial Services License
17th May 20243:30 pmRNSHolding(s) in Company
13th May 20246:20 pmRNSDirector/PDMR Dealings
13th May 20241:45 pmRNSPublication of Annual Report and Notice of AGM
9th May 20246:00 pmRNSResult of Placing and Retail Offer
9th May 202410:40 amRNSDirector / PDMR Dealing
3rd May 20247:00 amRNSRetail Offer
2nd May 20245:55 pmRNSResults of Placing
2nd May 20247:01 amRNSProposed Fundraise
2nd May 20247:00 amRNSFull Year Results For the Year Ended 31/12/2023
17th Apr 20247:00 amRNSHolding(s) in Company
27th Feb 20247:00 amRNSHolding(s) in Company
23rd Feb 20247:00 amRNSHolding(s) in Company
14th Feb 20247:00 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSHolding(s) in Company
30th Jan 20247:00 amRNSTrading Update and CFO appointment
23rd Nov 20237:00 amRNSDirector/PDMR Dealing
21st Nov 20234:12 pmRNSDirector/PDMR Dealing
16th Nov 20239:23 amRNSAppointment of Non-executive Director
10th Nov 20237:00 amRNSTrading Statement
9th Nov 20233:18 pmRNSStandard form for notification of major holdings
9th Nov 20237:00 amRNSBoard Change
6th Nov 20239:35 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.